Journey Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.09M Buy
6,150
+5,273
+601% +$2.53M 0.24% 102
2026
Q1
$431K Sell
877
-107
-11% -$58.1K 0.04% 191
2025
Q4
$570K Sell
984
-1
-0.1% -$566 0.05% 182
2025
Q3
$478K Sell
985
-5,455
-85% -$2.54M 0.04% 195
2025
Q2
$2.61M Buy
+6,440
New +$2.69M 0.2% 109
2025
Q1
Sell
-387
Closed -$214K 291
2024
Q4
$214K Hold
387
0.03% 221
2024
Q3
$214K Hold
387
0.03% 221
2024
Q2
$214K Hold
387
0.03% 220
2024
Q1
$225K Hold
387
0.03% 224
2023
Q4
$205K Buy
+387
New +$187K 0.03% 212
2023
Q3
Sell
-393
Closed -$205K 224
2023
Q2
$205K Sell
393
-253
-39% -$137K 0.03% 221
2023
Q1
$372K Sell
646
-269
-29% -$152K 0.06% 169
2022
Q4
$504K Sell
915
-36
-4% -$19.1K 0.13% 128
2022
Q3
$482K Buy
951
+30
+3% +$16.8K 0.12% 141
2022
Q2
$543K Buy
921
+90
+11% +$49.5K 0.12% 141
2022
Q1
$491K Buy
831
+11
+1% +$6.32K 0.12% 136
2021
Q4
$547K Buy
820
+66
+9% +$41.2K 0.15% 125
2021
Q3
$431K Buy
754
+35
+5% +$19.2K 0.14% 132
2021
Q2
$363K Buy
719
+41
+6% +$19.3K 0.12% 150
2021
Q1
$309K Buy
678
+39
+6% +$18.6K 0.11% 149
2020
Q4
$298K Buy
+639
New +$300K 0.11% 139

Other funds holding TMO

Journey Advisory Group's TMO Position: Q2 2026 in Review

Journey Advisory Group increased its Thermo Fisher Scientific (TMO) stake by 601% in Q2 2026, buying an estimated $2.53M and bringing the position to 6,150 shares worth $3.09M. The position accounts for 0.24% of the portfolio, ranked #102.

Journey Advisory Group first reported a position in TMO in Q4 2020 and has held it in 21 quarters since. 1,864 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Journey Advisory Group held 6,150 shares of Thermo Fisher Scientific worth $3.09M as of Q2 2026.
  • Journey Advisory Group bought 5,273 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.53M.
  • Thermo Fisher Scientific made up 0.24% of Journey Advisory Group's portfolio in Q2 2026, its #102 holding.
  • Journey Advisory Group first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 21 quarters since.
  • 1,864 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Journey Advisory Group's 13F filing for Q2 2026, filed 4 Aug 2026.